SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2004 / Cilt: 4 - Sayı: 3

The relationship between serum C-Reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test

Kararlı anjina pektorisi olan ve efor testi pozitif bulunan ayaktan hastalarda serum C-Reaktif protein düzeyleri ile koroner arter hastalığı ile İlişkisi

Cemil GÜRGÜN
Cüneyt TÜRKOĞLU
E. İpek TÜRKOĞLU
Mehdi ZOGHİ
Pages
199–202
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Objective: In this study we aimed to investigate whether serum C- reactive protein (CRP) levels are related with the incidence of coronary artery disease (CAD) and selection of management approaches in stable angina pectoris (SAP).Methods: Overall 134 patients (pts) with SAP and positive exercise stress test were investigated.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study we aimed to investigate whether serum C- reactive protein (CRP) levels are related with the incidence of coronary artery disease (CAD) and selection of management approaches in stable angina pectoris (SAP).Methods: Overall 134 patients (pts) with SAP and positive exercise stress test were investigated.
📊
Key Findings & Data:All pts were divided into two groups according to the baseline levels of CRP.
💡
Conclusion & Impact:In group 1 (mean age 57.8±10.3 years) there were 41 pts with the level of CRP >0.50mg/dl (high levels of CRP) and group 2 consisted of 93 pts (mean age 56.0±11.7 years) with the CRP levels
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study we aimed to investigate whether serum C- reactive protein (CRP) levels are related with the incidence of coronary artery disease (CAD) and selection of management approaches in stable angina pectoris (SAP).Methods: Overall 134 patients (pts) with SAP and positive exercise stress test were investigated. All pts were divided into two groups according to the baseline levels of CRP. In group 1 (mean age 57.8±10.3 years) there were 41 pts with the level of CRP >0.50mg/dl (high levels of CRP) and group 2 consisted of 93 pts (mean age 56.0±11.7 years) with the CRP levels

Özet

Amaç: Bu çalışmada, kararlı anjina pektoris tanımlayan ve efor testi pozitif bulunan ayaktan hastalardaki serum C-reaktif protein (CRP) düzeyiyle koroner arter hastalığının (KAH) sıklığı ve tedavi seçimi arasındaki ilişkiyi araştırdık. Yöntem: Kararlı anjinası olan ve efor testi pozitif bulunan 134 hasta çalışmaya alındı. Tüm hastalar CRP düzeylerine göre iki gruba ayrıldılar. Birinci grup (Grup 1I), CRP düzeyi >0.50 mg/dl (yüksek CRP düzeyi) olan ve ortalama yaşları 57.8±10.3 yıl olan 41 hastadan oluşmaktaydı. İkinci grupta (Grup 2) ise CRP düzeyi

🔖

Cite This Article

GÜRGÜN, C., TÜRKOĞLU, C., TÜRKOĞLU, E. İ., ZOGHİ, M. (2022). The relationship between serum C-Reactive protein levels and coronary artery disease in patients with stable angina pectoris and positive exercise stress test. Anadolu Kardiyoloji Dergisi, Cilt: 4 - Sayı: 3, 199–202. https://ajindex.com/articles/437473

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analysis. BMJ 2000; 321:199-204
  2. Lagrand WK, Visser CA, Hermens WT, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999; 100: 96-102
  3. Packard CJ, O’Reilly DSJ, Caslake MJ, et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med 2000; 343:1148-55
  4. Kuller LH, Tracy RP, Shaten J, et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial. Am J Epidemiol 1996; 144:537-47
  5. Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992. Circulation 1999: 99: 237-42
  6. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999; 106: 506-12
  7. Jager A, van Hisberg VW, Kostense PJ, et al. Von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol 1999; 19: 3071-8
  8. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731-3
  9. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43
  10. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001; 344: 1959-65
  11. Kervinen H, Palosuo T, Manninen V, et al. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J 2001; 141: 580-5. 12. de Beer FC, Hind CRK, Fox KM, et al. Measurement of serum C-reactive protein concentration in myocardial ischeamia and infarction. Br Heart J 1982; 47: 239-43
  12. Pietila K, Harmoinen A, Teppo A. Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator. Ann Med 1991; 23: 529-35